Notably, loss of TGFβ receptor (TGFβR2) in tumor lesions led to T cell exclusion and enrichment of a TGFβ-activated lung fibroblast signature, indicating stroma remodeling and a more immunosuppressive TME (22). The gene discussed is TGFBR2; the disease is neoplasm.